Learn about a novel biological therapy for atopic eczema, dupilumab, which is on a fast-track to FDA approval. How is it clarifying our understanding of the pathogenesis of this chronic disease?
almost 4 years ago
Surveillance for Certain Health Behaviors, Chronic Diseases, and Conditions, Access to Health Care, and Use of Preventive Health Services Among States and Selected Local Areas — Behavioral Risk Factor Surveillance System, United States, 2012 | MMWR
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC).
over 3 years ago